Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Letrozole in the Treatment of Metastatic Breast Cancer in Combination With Chemotherapy

NCT00333047 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00333047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00333047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Letrozole in the Treatment of Metastatic Breast Cancer in Combination With Chemotherapy
Lead sponsor
Novartis
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2002
Completion date
Not reported
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer